NASDAQ:MEDP Medpace (MEDP) Stock Price, News & Analysis $626.05 -7.93 (-1.25%) As of 10:16 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Medpace Stock (NASDAQ:MEDP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Medpace alerts:Sign Up Key Stats Today's Range$623.77▼$633.8750-Day Range$587.52▼$692.6852-Week Range$373.00▼$693.97Volume23,419 shsAverage Volume321,146 shsMarket Capitalization$17.51 billionP/E Ratio34.80Dividend YieldN/APrice Target$649.27Consensus RatingHold Company Overview Medpace Holdings, Inc. is a global contract research organization (CRO) that provides clinical development services to the biotechnology, pharmaceutical and medical device industries. Founded in 1992 and headquartered in Cincinnati, Ohio, the company works with clients developing treatments and medical products across a range of therapeutic areas. Medpace offers services spanning the clinical development process, including clinical trial planning and management, regulatory affairs, clinical laboratory testing, data management, biostatistics, medical writing and pharmacovigilance. Its work supports studies from early development through later-stage trials and regulatory submission. The company serves clients internationally, with operations across the Americas, Europe and Asia. Medpace was founded by August Troendle, who continues to lead the company as its chief executive officer.AI Generated. May Contain Errors. Read More Medpace Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks53rd Percentile Overall ScoreMEDP MarketRank™: 2.670790378005 of 5 starsMedpace scored higher than 53% of companies evaluated by MarketBeat, and ranked 438th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.3 / 5Analyst RatingHold Consensus RatingMedpace has received a consensus rating of Hold. The company's average rating score is 2.23, and is based on no strong buy ratings, 3 buy ratings, 10 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for Medpace is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageMedpace has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Medpace's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth8.14% Earnings GrowthEarnings for Medpace are expected to grow by 8.14% in the coming year, from $18.06 to $19.53 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medpace is 35.14, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.10.Price to Earnings Ratio vs. SectorThe P/E ratio of Medpace is 35.14, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 33.21.Price to Earnings Growth RatioMedpace has a PEG Ratio of 2.51. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioMedpace has a P/B Ratio of 30.32. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Medpace's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted6.23% of the float of Medpace has been sold short.Short Interest Ratio / Days to CoverMedpace has a short interest ratio ("days to cover") of 3.46, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Medpace has recently decreased by 14.15%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMedpace does not currently pay a dividend.Dividend GrowthMedpace does not have a long track record of dividend growth. News and Social Media3.1 / 5News Sentiment0.94 News SentimentMedpace has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Medpace this week, compared to 8 articles on an average week.Search Interest2 people have searched for MEDP on MarketBeat in the last 30 days. MarketBeat FollowsOnly 5 people have added Medpace to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Medpace insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $174,850,299.00 in company stock.Percentage Held by Insiders20.50% of the stock of Medpace is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions77.98% of the stock of Medpace is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Medpace's insider trading history. Receive MEDP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medpace and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MEDP Stock News HeadlinesMedpace Holdings, Inc. (MEDP) - What Are Analysts Saying About This Stock?November 18 at 2:14 AM | americanbankingnews.comAre Options Traders Betting on a Big Move in Medpace Stock?November 16, 2026 | msn.comYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which stock, what price, and when to exit. The list reads the same whether you've traded for twenty years or twenty days, and it doesn't depend on account size. If it's not for you, refund the $7 and still keep the scanner for the full year. One payment, no re-bills.November 20 at 1:00 AM | Profits Run (Ad)If You Invested $1000 in Medpace a Decade Ago, This is How Much It'd Be Worth NowNovember 6, 2026 | finance.yahoo.comDid Earnings Beat Just Shift Medpace Holdings (MEDP) Investment Narrative?November 5, 2026 | finance.yahoo.comMedpace (NASDAQ:MEDP) Stock: Insider Stephen Ewald Sells 1,245 SharesNovember 3, 2026 | insidertrades.comMedpace Holdings consensus price target increased by 14.03% to €597.83November 2, 2026 | msn.comMedpace (NASDAQ:MEDP) VP Susan Burwig Sells 3,940 Shares of Company StockOctober 29, 2026 | insidertrades.comSee More Headlines MEDP Stock Analysis - Frequently Asked Questions How have MEDP shares performed this year? Medpace's stock was trading at $561.65 at the beginning of the year. Since then, MEDP shares have increased by 12.9% and is now trading at $633.98. How were Medpace's earnings last quarter? Medpace Holdings, Inc. (NASDAQ:MEDP) released its quarterly earnings results on Wednesday, October, 21st. The company reported $4.84 earnings per share for the quarter, topping the consensus estimate of $4.44 by $0.40. The business's quarterly revenue was up 8.5% compared to the same quarter last year. Read the conference call transcript. When did Medpace IPO? Medpace (MEDP) raised $150 million in an initial public offering (IPO) on Thursday, August 11th 2016. The company issued 7,000,000 shares at $20.00-$23.00 per share. Jefferies, Credit Suisse, UBS Investment Bank and Wells Fargo Securities served as the underwriters for the IPO and Baird and William Blair were co-managers. Who are Medpace's major shareholders? Top institutional shareholders of Medpace include Aberdeen Group plc (7.98%), State Street Corp (2.55%), Bessemer Group Inc. (1.01%) and Stephens Investment Management Group LLC (0.64%). Insiders that own company stock include Medpace Investors, Llc, August J Troendle, Susan E Burwig, Brian T Carley, Stephen P Ewald, Jesse J Geiger, Kevin M Brady, Cornelius P Mccarthy III, Fred B Davenport Jr, Robert O Kraft and Ashley M Keating. View institutional ownership trends. How do I buy shares of Medpace? Shares of MEDP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Medpace own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medpace investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), PayPal (PYPL), Shopify (SHOP), Tesla (TSLA), Arista Networks (ANET) and Broadcom (AVGO). Company Calendar Last Earnings10/21/2026Today11/20/2026Fiscal Year End12/31/2026Next Earnings (Estimated)2/08/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 MEDP's financial health is in the Green zone, according to TradeSmith. MEDP has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:MEDP CIK1668397 Webwww.medpace.com Phone(513) 579-9911Fax513-579-0444Employees6,200Year Founded1992Price Target and Rating Average Price Target for Medpace$649.27 High Price Target$730.00 Low Price Target$515.00 Potential Upside/Downside+2.4%Consensus RatingHold Rating Score (0-4)2.23 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)$18.04 Trailing P/E Ratio35.14 Forward P/E Ratio32.46 P/E Growth2.51Net Income$451.12 million Net Margins18.24% Pretax Margin22.09% Return on Equity99.76% Return on Assets24.47% Debt Debt-to-Equity RatioN/A Current Ratio0.83 Quick Ratio0.83 Sales & Book Value Annual Sales$2.84 billion Price / Sales6.25 Cash Flow$16.67 per share Price / Cash Flow38.02 Book Value$20.91 per share Price / Book30.32Miscellaneous Outstanding Shares27,972,000Free Float22,238,000Market Cap$17.73 billion OptionableOptionable Beta1.12 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NASDAQ:MEDP) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredI'm handing you this one freeDylan has tracked down the company behind what he calls the StarChip. It's already inside more than 10,000 Sta...Behind the Markets | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medpace Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medpace With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.